What’s next for obesity?

Solid proof now exists that pharmacological intervention can help shift excess body weight. Yet, many questions remain, including: What’s the potential market size? How much is the pipeline worth? Which mechanisms show the most promise? Where are investors directing their attention? This infographic attempts to start answering these questions, drawing on data from Evaluate Omnium. […]

Share:

Download today








Solid proof now exists that pharmacological intervention can help shift excess body weight. Yet, many questions remain, including:

  • What’s the potential market size?
  • How much is the pipeline worth?
  • Which mechanisms show the most promise?
  • Where are investors directing their attention?

This infographic attempts to start answering these questions, drawing on data from Evaluate Omnium. Using machine learning to analyse millions of data points, Evaluate Omnium provides powerful visibility into the commercial potential and development risks of pharmaceutical assets at all phases of development.

Upcoming Webinar

China Pipelines, Western Portfolios

Tuesday 14th July 3pm BST | 10am ET

Western pharma committed close to $2 billion in licensing deals and acquisitions for China-originated assets in Q1 2026 alone.

Related Content